2cureX appoints two internationally highly recognized oncologists as Clinical Advisors
2cureX AB, a company pioneering the use of 3D microtumors in designing efficacious cancer treatment for the individual patient, announced today that Dr. John Lindsay Marshall, from Georgetown University Hospital, Washington DC, US and Dr Jesús García-Foncillas, from University Hospital Fundación Jimenez Diaz, Madrid, Spain have joined 2cureX Clinical Advisory Board.“2cureX is honored that Dr. John L. Marshall and Dr. Jesús García-Foncillas have accepted to assist us in defining the next generation of personalized oncology tools based on the IndiTreat® test. Not only will 2cureX benefit from